Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review

Abbayya, 2015, Association between Periodontitis and Alzheimer’s Disease, N. Am. J. Med. Sci., 7, 241, 10.4103/1947-2714.159325

Alzheimer, 1991, On certain peculiar diseases of old age, Hist. Psychiatry, 2, 71, 10.1177/0957154X9100200505

Bai, 2014, Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities, Alzheimer Dis. Assoc. Disord., 28, 226, 10.1097/WAD.0000000000000022

Balistreri, 2008, Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer’s disease, Curr. Pharm. Des., 14, 2672, 10.2174/138161208786264089

Banks, 2010, The blood-brain barrier and immune function and dysfunction, Neurobiol. Dis., 37, 26, 10.1016/j.nbd.2009.07.031

Banks, 2015, Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit, J. Neuroinflammation, 12, 223, 10.1186/s12974-015-0434-1

Bartzokis, 2011, Alzheimer’s disease as homeostatic responses to age-related myelin breakdown, Neurobiol. Aging, 32, 1341, 10.1016/j.neurobiolaging.2009.08.007

Belkacemi, 2012, Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer’s disease related to the amyloid-β cascade, Free Radic. Biol. Med., 52, 593, 10.1016/j.freeradbiomed.2011.11.020

Bertram, 2010, The genetics of Alzheimer disease: back to the future, Neuron, 68, 270, 10.1016/j.neuron.2010.10.013

Bertram, 2012, The genetics of Alzheimer’s disease, Prog. Mol. Biol. Transl. Sci., 107, 79, 10.1016/B978-0-12-385883-2.00008-4

Bester, 2015, Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia and the possible role of bacterial lipopolysaccharides (LPS), Oncotarget, 6, 35284, 10.18632/oncotarget.6074

Blanco, 2012, Diversity, biogenesis and function of microbial amyloids, Trends Microbiol., 20, 66, 10.1016/j.tim.2011.11.005

Branton, 2013, Brain microbial populations in HIV/AIDS: α-proteobacteria predominate independent of host immune status, PLoS One, 8, e54673, 10.1371/journal.pone.0054673

Branton, 2016, Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis, Sci. Rep., 6, 37344, 10.1038/srep37344

Brickman, 2008, Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease, Arch. Neurol., 65, 1202, 10.1001/archneur.65.9.1202

Buggia-Prevot, 2008, NFκB-dependent control of BACE1 promoter transactivation by Aβ42, J. Biol. Chem., 283, 10037, 10.1074/jbc.M706579200

Butchart, 2012, Systemic and central immunity in Alzheimer’s disease: therapeutic implications, CNS Neurosci. Ther., 18, 64, 10.1111/j.1755-5949.2011.00245.x

Cattaneo, 2017, Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly, Neurobiol. Aging, 49, 60, 10.1016/j.neurobiolaging.2016.08.019

Cavanaugh, 2014, Animal models of Alzheimer disease: historical pitfalls and a path forward, ALTEX, 31, 279, 10.14573/altex.1310071

Chen, 2017, Association between chronic periodontitis and the risk of Alzheimer’s disease: a retrospective, population-based, matched-cohort study, Alzheimers. Res. Ther., 9, 56, 10.1186/s13195-017-0282-6

Chen, 2012, Sequence variants of toll like receptor 4 and late-onset Alzheimer’s disease, PLoS One, 7, e50771, 10.1371/journal.pone.0050771

Civitelli, 2015, Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimer’s disease pathogenesis, J. Neurovirol., 21, 480, 10.1007/s13365-015-0344-0

Couttas, 2016, Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer’s disease, Neurobiol. Aging, 43, 89, 10.1016/j.neurobiolaging.2016.03.027

Crehan, 2012, Complement receptor 1 (CR1) and Alzheimer’s disease, Immunobiology, 217, 244, 10.1016/j.imbio.2011.07.017

de Craen, 2005, Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia, Am. J. Epidemiol., 161, 114, 10.1093/aje/kwi029

de Haas, 2000, Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation, Infect. Immun., 68, 1753, 10.1128/iai.68.4.1753-1759.2000

de la Torre, 2009, Cerebrovascular and cardiovascular pathology in Alzheimer’s disease, Int. Rev. Neurobiol., 84, 35, 10.1016/s0074-7742(09)00403-6

Deng, 2008, Progress in periventricular leukomalacia, Arch. Neurol., 65, 1291, 10.1001/archneur.65.10.1291

Deng, 2014, Astrocyte-derived proinflammatory cytokines induce hypomyelination in the periventricular white matter in the hypoxic neonatal brain, PLoS One, 9, e87420, 10.1371/journal.pone.0087420

Desai, 2010, Early oligodendrocyte/myelin pathology in Alzheimer’s disease mice constitutes a novel therapeutic target, Am. J. Pathol., 177, 1422, 10.2353/ajpath.2010.100087

Dunn, 2005, Association between dementia and infectious disease: evidence from a case-control study, Alzheimer Dis. Assoc. Disord., 19, 91, 10.1097/01.wad.0000165511.52746.1f

Emery, 2017, 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain, Front. Aging Neurosci., 9, 195, 10.3389/fnagi.2017.00195

Engelhart, 2004, Inflammatory proteins in plasma and the risk of dementia: the rotterdam study, Arch. Neurol., 61, 668, 10.1001/archneur.61.5.668

Englund, 1998, Neuropathology of white matter changes in Alzheimer’s disease and vascular dementia, Dement. Geriatr. Cogn. Disord., 9, 6, 10.1159/000051183

Enkhbaatar, 2015, Comparison of gene expression by sheep and human blood stimulated with the TLR4 agonists lipopolysaccharide and monophosphoryl lipid A, PLoS One, 10, e0144345, 10.1371/journal.pone.0144345

Erickson, 2012, Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier, J. Neuroinflammation, 9, 150, 10.1186/1742-2094-9-150

Erridge, 2010, Endogenous ligands of TLR2 and TLR4: agonists or assistants?, J. Leukoc. Biol., 87, 989, 10.1189/jlb.1209775

Fan, 2009, Interleukin-1β-induced brain injury in the neonatal rat can be ameliorated by α-phenyl-n-tert-butyl-nitrone, Exp. Neurol., 220, 143, 10.1016/j.expneurol.2009.08.003

Fassbender, 2004, The LPS receptor (CD14) links innate immunity with Alzheimer’s disease, FASEB J., 18, 203, 10.1096/fj.03-0364fje

Gaultier, 2009, Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis, J. Cell Sci., 122, 1155, 10.1242/jcs.040717

Goate, 2012, Twenty years of Alzheimer’s disease-causing mutations, J. Neurochem., 120, 3, 10.1111/j.1471-4159.2011.07575.x

Grammas, 2011, Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer’s disease, J. Neuroinflammation, 8, 26, 10.1186/1742-2094-8-26

Guglielmotto, 2012, Aβ1–42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation, Aging Cell, 11, 834, 10.1111/j.1474-9726.2012.00854.x

Guglielmotto, 2009, Oxidative stress and hypoxia contribute to Alzheimer’s disease pathogenesis: two sides of the same coin, ScientificWorldJournal, 9, 781, 10.1100/tsw.2009.93

Hagberg, 2002, Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults, Ment. Retard. Dev. Disabil. Res. Rev., 8, 30, 10.1002/mrdd.10007

Hall, 2012, Mouse models of Alzheimer’s disease, Brain Res. Bull., 88, 3, 10.1016/j.brainresbull.2011.11.017

Hammond, 2010, Immunohistological detection of Chlamydia pneumoniae in the Alzheimer’s disease brain, BMC Neurosci., 11, 121, 10.1186/1471-2202-11-121

Heneka, 2015, Neuroinflammation in Alzheimer’s disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5

Herholz, 2010, Cerebral glucose metabolism in preclinical and prodromal Alzheimer’s disease, Expert Rev. Neurother., 10, 1667, 10.1586/ern.10.136

Herrup, 2015, The case for rejecting the amyloid cascade hypothesis, Nat. Neurosci., 18, 794, 10.1038/nn.4017

Hill, 2015, Microbial-generated amyloids and Alzheimer’s disease (AD), Front. Aging Neurosci., 7, 9, 10.3389/fnagi.2015.00009

Horiuchi, 2012, Amyloid β1–42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007

Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell, 148, 1204, 10.1016/j.cell.2012.02.040

Hunt, 2007, Reduced cerebral glucose metabolism in patients at risk for Alzheimer’s disease, Psychiatry Res., 155, 147, 10.1016/j.pscychresns.2006.12.003

Iadecola, 2004, Neurovascular regulation in the normal brain and in Alzheimer’s disease, Nat. Rev. Neurosci., 5, 347, 10.1038/nrn1387

Iadecola, 2013, The pathobiology of vascular dementia, Neuron, 80, 844, 10.1016/j.neuron.2013.10.008

Iadecola, 1999, SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein, Nat. Neurosci., 2, 157, 10.1038/5715

Ikeda, 1999, Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection, Biosci. Biotechnol. Biochem., 63, 1006, 10.1271/bbb.63.1006

Imbimbo, 2009, An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer’s disease, Expert Opin. Investig. Drugs, 18, 1147, 10.1517/13543780903066780

Imbimbo, 2010, Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment?, Front. Aging Neurosci., 2, 19, 10.3389/fnagi.2010.00019

Ishida, 2017, Periodontitis induced by bacterial infection exacerbates features of Alzheimer’s disease in transgenic mice, NPJ Aging Mech. Dis., 3, 15, 10.1038/s41514-017-0015-x

Kamer, 2015, Periodontal disease associates with higher brain amyloid load in normal elderly, Neurobiol. Aging, 36, 627, 10.1016/j.neurobiolaging.2014.10.038

Kandel, 2016, White matter hyperintensities are more highly associated with preclinical Alzheimer’s disease than imaging and cognitive markers of neurodegeneration, Alzheimers Dement., 4, 18, 10.1016/j.dadm.2016.03.001

Karch, 2015, Alzheimer’s disease risk genes and mechanisms of disease pathogenesis, Biol. Psychiatry, 77, 43, 10.1016/j.biopsych.2014.05.006

Kitazawa, 2005, Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease, J. Neurosci., 25, 8843, 10.1523/JNEUROSCI.2868-05.2005

Kotarba, 2013, Fine mapping of the amyloid β-protein binding site on myelin basic protein, Biochemistry, 52, 2565, 10.1021/bi4001936

Kountouras, 2009, Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease, Int. J. Neurosci., 119, 765, 10.1080/00207450902782083

Kuo, 2005, Relation of C-reactive protein to stroke, cognitive disorders and depression in the general population: systematic review and meta-analysis, Lancet Neurol., 4, 371, 10.1016/s1474-4422(05)70099-5

Lee, 2010, LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice, J. Neuroinflammation, 7, 56, 10.1186/1742-2094-7-56

Lee, 2016, White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the Dominantly Inherited Alzheimer Network, Ann. Neurol., 79, 929, 10.1002/ana.24647

Lehnardt, 2002, The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS, J. Neurosci., 22, 2478, 10.1523/JNEUROSCI.22-07-02478.2002

Lehnardt, 2003, Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway, Proc. Natl. Acad. Sci. U S A, 100, 8514, 10.1073/pnas.1432609100

Li, 2015, Integrated genomic approaches identify major pathways and upstream regulators in late onset alzheimer’s disease, Sci. Rep., 5, 12393, 10.1038/srep12393

Li, 2008, Tumor necrosis factor α mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present, J. Neurosci., 28, 5321, 10.1523/JNEUROSCI.3995-07.2008

Liao, 2009, Degradation of amyloid β protein by purified myelin basic protein, J. Biol. Chem., 284, 28917, 10.1074/jbc.M109.050856

Liao, 2010, N-terminal domain of myelin basic protein inhibits amyloid β-protein fibril assembly, J. Biol. Chem., 285, 35590, 10.1074/jbc.M110.169599

Liu, 2005, LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide, Brain, 128, 1778, 10.1093/brain/awh531

Liu, 2016, Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A, J. Neuroinflammation, 13, 28, 10.1186/s12974-016-0493-y

Lovheim, 2018, Interaction between cytomegalovirus and herpes simplex virus type 1 associated with the risk of Alzheimer’s disease development, J. Alzheimers Dis., 61, 939, 10.3233/JAD-161305

Marlatt, 2008, Alzheimer’s disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies, J. Alzheimers Dis., 15, 199, 10.3233/jad-2008-15206

McGeer, 1996, Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies, Neurology, 47, 425, 10.1212/WNL.47.2.425

Meyer, 2008, Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer’s disease, Proc. Natl. Acad. Sci. U S A, 105, 3587, 10.1073/pnas.0709788105

Miklossy, 1993, Alzheimer’s disease—a spirochetosis?, Neuroreport, 4, 841, 10.1097/00001756-199307000-00002

Miklossy, 1994, Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer’s disease, Neuroreport, 5, 1201, 10.1097/00001756-199406020-00010

Miklossy, 2004, Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease, J. Alzheimers Dis., 6, 673, 10.3233/jad-2004-6608

Minter, 2016, Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease, Sci. Rep., 6, 30028, 10.1038/srep30028

Mitew, 2010, Focal demyelination in Alzheimer’s disease and transgenic mouse models, Acta Neuropathol., 119, 567, 10.1007/s00401-010-0657-2

Möller, 1998, The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections, Eur. Arch. Psychiatry Clin. Neurosci., 248, 111, 10.1007/s004060050027

Montagne, 2015, Blood-brain barrier breakdown in the aging human hippocampus, Neuron, 85, 296, 10.1016/j.neuron.2014.12.032

Montagne, 2017, Alzheimer’s disease: a matter of blood-brain barrier dysfunction?, J. Exp. Med., 214, 3151, 10.1084/jem.20171406

Noble, 2014, Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease, PLoS One, 9, e114959, 10.1371/journal.pone.0114959

O’Brien, 2011, Amyloid precursor protein processing and Alzheimer’s disease, Annu. Rev. Neurosci., 34, 185, 10.1146/annurev-neuro-061010-113613

Olsen, 2015, Can oral infection be a risk factor for Alzheimer’s disease?, J. Oral. Microbiol., 7, 29143, 10.3402/jom.v7.29143

Ou-Yang, 2013, The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice, J. Neuroinflammation, 10, 134, 10.1186/1742-2094-10-134

Paintlia, 2008, Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine, Exp. Neurol., 210, 560, 10.1016/j.expneurol.2007.12.011

Pang, 2003, Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide, Dev. Brain Res., 140, 205, 10.1016/s0165-3806(02)00606-5

Pang, 2010, Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development, Neuroscience, 166, 464, 10.1016/j.neuroscience.2009.12.040

Papuc, 2015, Can antibodies against glial derived antigens be early biomarkers of hippocampal demyelination and memory loss in Alzheimer’s disease?, J. Alzheimers Dis., 48, 115, 10.3233/JAD-150309

Pisa, 2015, Direct visualization of fungal infection in brains from patients with Alzheimer’s disease, J. Alzheimers Dis., 43, 613, 10.3233/JAD-141386

Poole, 2013, Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue, J. Alzheimers Dis., 36, 665, 10.3233/JAD-121918

Potgieter, 2015, The dormant blood microbiome in chronic, inflammatory diseases, FEMS Microbiol. Rev., 39, 567, 10.1093/femsre/fuv013

Rahkonen, , Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: a 2 year follow up study, J. Neurol. Neurosurg. Psychiatry, 69, 519, 10.1136/jnnp.69.4.519

Rahkonen, , Delirium in elderly people without severe predisposing disorders: etiology and 1-year prognosis after discharge, Int. Psychogeriatr., 12, 473, 10.1017/s1041610200006591

Raziuddin, 1981, Binding of bacterial endotoxin (LPS) to encephalitogenic myelin basic protein and modulation of characteristic biologic activities of LPS, J. Immunol., 126, 1030, 10.4049/jimmunol.126.3.1030

Reed-Geaghan, 2010, Deletion of CD14 attenuates Alzheimer’s disease pathology by influencing the brain’s inflammatory milieu, J. Neurosci., 30, 15369, 10.1523/JNEUROSCI.2637-10.2010

Riviere, 2002, Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease, Oral Microbiol. Immunol., 17, 113, 10.1046/j.0902-0055.2001.00100.x

Rodríguez-Rodríguez, 2008, Interaction between CD14 and LXRβ genes modulates Alzheimer’s disease risk, J. Neurol. Sci., 264, 97, 10.1016/j.jns.2007.08.001

Rossol, 2011, LPS-induced cytokine production in human monocytes and macrophages, Crit. Rev. Immunol., 31, 379, 10.1615/critrevimmunol.v31.i5.20

Ruitenberg, 2005, Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study, Ann. Neurol., 57, 789, 10.1002/ana.20493

Sampson, 2016, Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease, Cell, 167, 1469.e12, 10.1016/j.cell.2016.11.018

Savva, 2009, Age, neuropathology, and dementia, N. Engl. J. Med., 360, 2302, 10.1056/NEJMoa0806142

Scheltens, 1995, Histopathologic correlates of white matter changes on MRI in Alzheimer’s disease and normal aging, Neurology, 45, 883, 10.1212/WNL.45.5.883

Schmidt, 2002, Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study, Ann. Neurol., 52, 168, 10.1002/ana.10265

Schneider, 2007, Mixed brain pathologies account for most dementia cases in community-dwelling older persons, Neurology, 69, 2197, 10.1212/01.WNL.0000271090.28148.24

Scott, 2017, Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship, Biochim. Biophys. Acta, 1862, 1439, 10.1016/j.bbalip.2017.01.004

Selkoe, 2011, Alzheimer’s disease, Cold Spring Harb. Perspect. Biol., 3, a004457, 10.1101/cshperspect.a004457

Selmaj, 1988, Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro, Ann. Neurol., 23, 339, 10.1002/ana.410230405

Sharon, 2016, The central nervous system and the gut microbiome, Cell, 167, 915, 10.1016/j.cell.2016.10.027

Sheline, 2010, APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42, J. Neurosci., 30, 17035, 10.1523/JNEUROSCI.3987-10.2010

Shen, 2017, Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state, J. Alzheimers Dis., 56, 385, 10.3233/JAD-160884

Sheng, 2003, Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice, Neurobiol. Dis., 14, 133, 10.1016/s0969-9961(03)00069-x

Stein, 2007, Tooth loss, dementia and neuropathology in the Nun study, J. Am. Dent. Assoc., 138, 1381, 10.14219/jada.archive.2007.0046

Tan, 2007, Inflammatory markers and the risk of Alzheimer disease: the Framingham Study, Neurology, 68, 1902, 10.1212/01.WNL.0000263217.36439.da

Tilvis, 2004, Predictors of cognitive decline and mortality of aged people over a 10-year period, J. Gerontol. A Biol. Sci. Med. Sci., 59, 268, 10.1093/gerona/59.3.m268

Tyas, 2001, Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba, Canada, Int. J. Epidemiol., 30, 590, 10.1093/ije/30.3.590

Ujiie, 2003, Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model, Microcirculation, 10, 463, 10.1038/sj.mn.7800212

van de Haar, , Blood-brain barrier leakage in patients with early Alzheimer disease, Radiology, 281, 527, 10.1148/radiol.2016152244

van de Haar, , Neurovascular unit impairment in early Alzheimer’s disease measured with magnetic resonance imaging, Neurobiol. Aging, 45, 190, 10.1016/j.neurobiolaging.2016.06.006

van de Haar, 2017, Subtle blood-brain barrier leakage rate and spatial extent: considerations for dynamic contrast-enhanced MRI, Med. Phys., 44, 4112, 10.1002/mp.12328

Veerhuis, 2011, Histological and direct evidence for the role of complement in the neuroinflammation of AD, Curr. Alzheimer Res., 8, 34, 10.2174/156720511794604589

Verma, 2006, Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide, Brain Behav. Immun., 20, 449, 10.1016/j.bbi.2005.10.005

Verreault, 2001, Past exposure to vaccines and subsequent risk of Alzheimer’s disease, CMAJ, 165, 1495

Veurink, 2003, Genetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease, Ann. Hum. Biol., 30, 639, 10.1080/03014460310001620144

Villegas-Llerena, 2016, Microglial genes regulating neuroinflammation in the progression of Alzheimer’s disease, Curr. Opin. Neurobiol., 36, 74, 10.1016/j.conb.2015.10.004

Vlad, 2008, Protective effects of NSAIDs on the development of Alzheimer disease, Neurology, 70, 1672, 10.1212/01.WNL.0000311269.57716.63

Vogt, 2017, Gut microbiome alterations in Alzheimer’s disease, Sci. Rep., 7, 13537, 10.1038/s41598-017-13601-y

Vollmar, 2010, Active immunization with amyloid-β 1–42 impairs memory performance through TLR2/4-dependent activation of the innate immune system, J. Immunol., 185, 6338, 10.4049/jimmunol.1001765

Walter, 2007, Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease, Cell. Physiol. Biochem., 20, 947, 10.1159/000110455

White, 2005, Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study, J. Geriatr. Psychiatry Neurol., 18, 224, 10.1177/0891988705281872

Winek, 2016, The gut microbiome as therapeutic target in central nervous system diseases: implications for stroke, Neurotherapeutics, 13, 762, 10.1007/s13311-016-0475-x

Wu, 2017, Cathepsin B plays a critical role in inducing Alzheimer’s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice, Brain Behav. Immun., 65, 350, 10.1016/j.bbi.2017.06.002

Wu, 2012, Clusterin in Alzheimer’s disease, Adv. Clin. Chem., 56, 155, 10.1016/B978-0-12-394317-0.00011-X

Wu, 2015, The role of the TLR4/NF-κB signaling pathway in Aβ accumulation in primary hippocampal neurons, Sheng Li Xue Bao, 67, 319

Xie, 2016, IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats, Glia, 64, 583, 10.1002/glia.22950

Zenaro, 2015, Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin, Nat. Med., 21, 880, 10.1038/nm.3913

Zhan, , Inflammation combined with ischemia produces myelin injury and plaque-like aggregates of myelin, amyloid-β and AβPP in adult rat brain, J. Alzheimers Dis., 46, 507, 10.3233/JAD-143072

Zhan, , Myelin basic protein associates with AβPP, Aβ1–42, and amyloid plaques in cortex of Alzheimer’s disease brain, J. Alzheimers Dis., 44, 1213, 10.3233/JAD-142013

Zhan, 2014, Myelin injury and degraded myelin vesicles in Alzheimer’s disease, Curr. Alzheimer Res., 11, 232, 10.2174/1567205011666140131120922

Zhan, 2016, Gram-negative bacterial molecules associate with Alzheimer disease pathology, Neurology, 87, 2324, 10.1212/WNL.0000000000003391

Zhang, 2009, Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS), J. Neuroimmunol., 206, 121, 10.1016/j.jneuroim.2008.09.017

Zhao, , Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer’s disease brain, Front. Immunol., 8, 1064, 10.3389/fimmu.2017.01064

Zhao, , Secretory products of the human gi tract microbiome and their potential impact on Alzheimer’s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus, Front. Cell. Infect. Microbiol., 7, 318, 10.3389/fcimb.2017.00318

Zhao, 2015, Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease (AD), J. Nat. Sci., 1, e138

Zhao, 2014, Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro, J. Alzheimers Dis., 41, 835, 10.3233/JAD-131799

Zhou, 2006, A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide, J. Immunol., 177, 8103, 10.4049/jimmunol.177.11.8103

Zhu, 2007, Vascular oxidative stress in Alzheimer disease, J. Neurol. Sci., 257, 240, 10.1016/j.jns.2007.01.039

Zlokovic, 2005, Neurovascular mechanisms of Alzheimer’s neurodegeneration, Trends Neurosci., 28, 202, 10.1016/j.tins.2005.02.001

Zlokovic, 2008, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003

Zlokovic, 2011, Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders, Nat. Rev. Neurosci., 12, 723, 10.1038/nrn3114

Zlokovic, 1996, Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. U S A, 93, 4229, 10.1073/pnas.93.9.4229